1. Home
  2. ADXN vs NXPL Comparison

ADXN vs NXPL Comparison

Compare ADXN & NXPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Addex Therapeutics Ltd

ADXN

Addex Therapeutics Ltd

N/A

Current Price

$6.75

Market Cap

8.6M

Sector

Health Care

ML Signal

N/A

Logo NextPlat Corp

NXPL

NextPlat Corp

N/A

Current Price

$7.29

Market Cap

10.0M

ML Signal

N/A

Company Overview

Basic Information
Metric
ADXN
NXPL
Founded
2002
1997
Country
Switzerland
United States
Employees
2
180
Industry
Biotechnology: Pharmaceutical Preparations
Telecommunications Equipment
Sector
Health Care
Telecommunications
Exchange
Nasdaq
Nasdaq
Market Cap
8.6M
10.0M
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
ADXN
NXPL
Price
$6.75
$7.29
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
2.7K
7.0K
Earning Date
04-30-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$86.57
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.41
$0.34
52 Week High
$12.05
$7.40

Technical Indicators

Market Signals
Indicator
ADXN
NXPL
Relative Strength Index (RSI) 48.55 70.00
Support Level $6.04 $0.60
Resistance Level $7.40 N/A
Average True Range (ATR) 0.32 0.64
MACD -0.01 -0.17
Stochastic Oscillator 56.52 87.35

Price Performance

Historical Comparison
ADXN
NXPL

About ADXN Addex Therapeutics Ltd

Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment, which is the discovery, development, and commercialization of small-molecule pharmaceutical products.

About NXPL NextPlat Corp

NextPlat Corp is an e-commerce and healthcare company. Its e-commerce venues form an effective network serving thousands of consumers, enterprises, and governments. Its healthcare business is focused on improving the lives of patients with complex chronic diseases through patient and provider engagement and their partnerships with payors, pharmaceutical manufacturers, and distributors, offering a broad range of solutions to address the dispensing, delivery, dosing, and reimbursement of clinically intensive, high-cost drugs. The company operates in two segments: e-Commerce Operations involves acquiring and leasing an e-commerce platform; and Healthcare Operations provides TPA, data management, COVID-19 related diagnostics and vaccinations, prescription pharmaceuticals, and Others.

Share on Social Networks: